المؤلفون: L. T. Akhmedzhanova, E. V. Mandra, Л. Т. Ахмеджанова, Е. В. Мандра

المصدر: Meditsinskiy sovet = Medical Council; № 23 (2022); 86-92 ; Медицинский Совет; № 23 (2022); 86-92 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: альфа-липоевая кислота, chronic painful diabetic polyneuropathy, acute painful diabetic polyneuropathy, neuropathic pain, alpha-lipoic acid, хроническая болевая диабетическая полиневропатия, острая болевая диабетическая полиневропатия, невропатическая боль

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/7295/6517; Zheng Y., Ley S.H., Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. https://doi.org/10.1038/nrendo.2017.151.; Pop-Busui R., Boulton A.J., Feldman E.L., Bril V., Freeman R., Malik R.A. et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154. https://doi.org/10.2337/dc16-2042.; Andersen S.T., Witte D.R., Dalsgaard E.M., Andersen H., Nawroth P., Fleming T. et al. Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark. Diabetes Care. 2018;41(5):1068–1075. https://doi.org/10.2337/dc17-2062.; Prabodha L.B.L., Sirisena N.D., Dissanayake V.H.W. Susceptible and Prognostic Genetic Factors Associated with Diabetic Peripheral Neuropathy: A Comprehensive Literature Review. Int J Endocrinol. 2018:8641942. https://doi.org/10.1155/2018/8641942.; Dyck P.J., Albers J.W., Andersen H., Arezzo J.C., Biessels G.J., Bril V. et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27(7):620–628. https://doi.org/10.1002/dmrr.1226.; Boulton A.J.M., Armstrong D.G., Hardman M.J., Malone M., Embil J.M., Attinger C.E. et al. Diagnosis and Management of Diabetic Foot Infections. Arlington (VA): American Diabetes Association; 2020. https://doi.org/10.2337/db2020-01.; Selvarajah D., Kar D., Khunti K., Davies M.J., Scott A.R., Walker J., Tesfaye S. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7(12):938–948. https://doi.org/10.1016/S2213-8587(19)30081-6.; Abbott C.A., Malik R.A., van Ross E.R., Kulkarni J., Boulton A.J. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34(10):2220–2224. https://doi.org/10.2337/dc11-1108.; Rastogi A., Jude E.B. Novel treatment modalities for painful diabetic neuropathy. Diabetes Metab Syndr. 2021;15(1):287–293. https://doi.org/10.1016/j.dsx.2021.01.004.; Hosseini A., Abdollahi M. Diabetic neuropathy and oxidative stress: therapeutic perspectives. Oxid Med Cell Longev. 2013:168039. https://doi.org/10.1155/2013/168039.; Feldman E.L., Nave K.A., Jensen T.S., Bennett D.L.H. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron. 2017;93(6):1296–1313. https://doi.org/10.1016/j.neuron.2017.02.005.; Callaghan B.C., Gallagher G., Fridman V., Feldman E.L. Diabetic neuropathy: what does the future hold? Diabetologia. 2020;63(5):891–897. https://doi.org/10.1007/s00125-020-05085-9.; Rosenberger D.C., Blechschmidt V., Timmerman H., Wolff A., Treede R.D. Challenges of neuropathic pain: focus on diabetic neuropathy. J Neural Transm (Vienna). 2020;127(4):589–624. https://doi.org/10.1007/s00702-020-02145-7.; Hébert H.L., Veluchamy A., Torrance N., Smith B.H. Risk factors for neuropathic pain in diabetes mellitus. Pain. 2017;158(4):560–568. https://doi.org/10.1097/j.pain.0000000000000785.; Ziegler D., Landgraf R., Lobmann R., Reiners K., Rett K., Schnell O., Strom A. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). Diabetes Res Clin Pract. 2018;139:147–154. https://doi.org/10.1016/j.diabres.2018.02.043.; Themistocleous A.C., Ramirez J.D., Shillo P.R., Lees J.G., Selvarajah D., Orengo C. et al. The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. Pain. 2016;157(5):1132–1145. https://doi.org/10.1097/j.pain.0000000000000491.; Raputova J., Srotova I., Vlckova E., Sommer C., Üçeyler N., Birklein F. et al. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study. Pain. 2017;158(12):2340–2353. https://doi.org/10.1097/j.pain.0000000000001034.; Calvo M., Dawes J.M., Bennett D.L. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 2012;11(7):629–642. https://doi.org/10.1016/S1474-4422(12)70134-5.; Sloan G., Selvarajah D., Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400–420. https://doi.org/10.1038/s41574-021-00496-z.; Tesfaye S., Selvarajah D., Gandhi R., Greig M., Shillo P., Fang F., Wilkinson I.D. Diabetic peripheral neuropathy may not be as its name suggests: evidence from magnetic resonance imaging. Pain. 2016;157(Suppl. 1):S72–S80. https://doi.org/10.1097/j.pain.0000000000000465.; Watanabe K., Hirano S., Kojima K., Nagashima K., Mukai H., Sato T. et al. Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain. J Neurol Neurosurg Psychiatry. 2018;89(10):1082–1087. https://doi.org/10.1136/jnnp-2017-316601.; Selvarajah D., Heiberg-Gibbons F., Wilkinson I.D., Gandhi R., Tesfaye S. A magnetic resonance imaging volumetry study of regional brain atrophy in diabetic peripheral neuropathy. Diabetes. 2018;67(Suppl. 1):550-P. https://doi.org/10.2337/db18-550-P.; Divisova S., Vlckova E., Hnojcikova M., Skorna M., Nemec M., Dubovy P. et al. Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibres. J Peripher Nerv Syst. 2012;17(3):341–350. https://doi.org/10.1111/j.1529-8027.2012.00420.x.; Зиновьева О.Е., Ахмеджанова Л.Т., Остроумова Т.М., Солоха О.А., Янакаева Т.А. Ранняя диагностика вегетативной невропатии в амбулаторной практике. Нервные болезни. 2020;(4):69–74. https://doi.org/10.24412/2226-0757-2020-12248.; Gibbons C.H., Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015;138(Pt 1):43–52. https://doi.org/10.1093/brain/awu307.; Gibbons C.H. Treatment induced neuropathy of diabetes. Auton Neurosci. 2020;226:102668. https://doi.org/10.1016/j.autneu.2020.102668.; Максимова Н., Мошенина С. Диабетическая нейропатия, индуцированная лечением (синдром Элленберга). Врач. 2018;(9):53–57. https://doi.org/10.29296/25877305-2018-09-12.; Bellelli A., Santi D., Simoni M., Greco C. Diabetic Neuropathic Cachexia: A Clinical Case and Review of Literature. Life (Basel). 2022;12(5):680. https://doi.org/10.3390/life12050680.; Мозолевский Ю.В. Заболевания периферической нервной системы. М.: МЕДпресс-информ; 2019. 432 с.; Gibbons C.H. Treatment-Induced Neuropathy of Diabetes. Curr Diab Rep. 2017;17(12):127. https://doi.org/10.1007/s11892-017-0960-6.; Feldman E.L., Callaghan B.C., Pop-Busui R., Zochodne D.W., Wright D.E., Bennett D.L. et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41. https://doi.org/10.1038/s41572-019-0092-1.; Weisman A., Bril V., Ngo M., Lovblom L.E., Halpern E.M., Orszag A., Perkins B.A. Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters. PLoS ONE. 2013;8(3):e58783. https://doi.org/10.1371/journal.pone.0058783.; Andersson C., Guttorp P., Särkkä A. Discovering early diabetic neuropathy from epidermal nerve fiber patterns. Stat Med. 2016;35(24):4427–4442. https://doi.org/10.1002/sim.7009.; Аветисов С.Э., Черненкова Н.А., Сурнина З.В., Ахмеджанова Л.Т., Фокина А.С., Строков И.А. Возможности ранней диагностики диабетической полинейропатии на основе исследования нервных волокон роговицы. Вестник офтальмологии. 2020;136(5):155–162. https://doi.org/10.17116/oftalma2020136052155.; England J.D., Gronseth G.S., Franklin G., Carter G.T., Kinsella L.J., Cohen J.A. et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72(2):185–192. https://doi.org/10.1212/01.wnl.0000336370.51010.a1.; Sharma J.K., Rohatgi A., Sharma D. Diabetic autonomic neuropathy: a clinical update. J R Coll Physicians Edinb. 2020;50(3):269–273. https://doi.org/10.4997/JRCPE.2020.310.; Salehi B., Berkay Yılmaz Y., Antika G., Boyunegmez Tumer T., Fawzi Mahomoodally M., Lobine D. et al. Insights on the Use of α-Lipoic Acid for Therapeutic Purposes. Biomolecules. 2019;9(8):356. https://doi.org/10.3390/biom9080356.; Islam M.T. Antioxidant activities of dithiol alpha-lipoic acid. Bangladesh J Med Sci. 2009;8(3):46–51. https://doi.org/10.3329/bjms.v8i3.398.; Ziegler D., Hanefeld M., Ruhnau K.J., Meissner H.P., Lobisch M., Schütte K., Gries F.A. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995;38(12):1425–1433. https://doi.org/10.1007/BF00400603.; Ziegler D., Hanefeld M., Ruhnau K.J., Hasche H., Lobisch M., Schütte K. et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care. 1999;22(8):1296–1301. https://doi.org/10.2337/diacare.22.8.1296.; Ametov A.S., Barinov A., Dyck P.J., Hermann R., Kozlova N., Litchy W.J. et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care. 2003;26(3):770–776. https://doi.org/10.2337/diacare.26.3.770.; Ziegler D., Nowak H., Kempler P., Vargha P., Low P.A. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004;21(2):114–121. https://doi.org/10.1111/j.1464-5491.2004.01109.x.; El-Nahas M.R., Elkannishy G., Abdelhafez H., Elkhamisy E.T., El-Sehrawy A.A. Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study. Endocr Metab Immune Disord Drug Targets. 2020;20(9):1531–1534. https://doi.org/10.2174/1871530320666200506081407.; Patel K., Horak H., Tiryaki E. Diabetic neuropathies. Muscle Nerve. 2021;63(1):22–30. https://doi.org/10.1002/mus.27014.; Finnerup N.B., Attal N., Haroutounian S., McNicol E., Baron R., Dworkin R.H. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–173. https://doi.org/10.1016/S1474-4422(14)70251-0.; Dworkin R.H., Jensen M.P., Gammaitoni A.R., Olaleye D.O., Galer B.S. Symptom profiles differ in patients with neuropathic versus non-neuropathic pain. J Pain. 2007;8(2):118–126. https://doi.org/10.1016/j.jpain.2006.06.005.; Tesfaye S., Wilhelm S., Lledo A., Schacht A., Tölle T., Bouhassira D. et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The “COMBO-DN study” – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154(12):2616–2625. https://doi.org/10.1016/j.pain.2013.05.043.; Zilliox L., Russell J.W. Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine. Diabetes Metab Syndr Obes. 2010;3:7–17. https://doi.org/10.2147/DMSOTT.S4719.; Marshall A., Alam U., Themistocleous A., Calcutt N., Marshall A. Novel and Emerging Electrophysiological Biomarkers of Diabetic Neuropathy and Painful Diabetic Neuropathy. Clin Ther. 2021;43(9):1441–1456. https://doi.org/10.1016/j.clinthera.2021.03.020.; https://www.med-sovet.pro/jour/article/view/7295

الاتاحة: https://www.med-sovet.pro/jour/article/view/7295
https://doi.org/10.21518/2079-701X-2022-16-23-86-92